News | December 21, 2025
Replacing confusion with clarity: Global Cancer Care launches Mumbai ops to tackle detection delays
The initiative is focused on a problem that continues to plague cancer outcomes in India
The initiative is focused on a problem that continues to plague cancer outcomes in India
Takeda said zasocitinib was generally well tolerated, with a safety profile consistent with earlier studies
SandboxAQ will receive an upfront payment and could earn up to $200 million in milestone payments tied to preclinical, development, regulatory, and commercial achievements
The study found BIC/LEN to be statistically non-inferior to BIKTARVY, Gilead’s current standard-of-care therapy
The update promises to revolutionize laboratory workflows by optimizing resources
The expansion includes a larger technical and service team and increased local procurement
If cleared by regulators, CagriSema would become the first treatment to combine a GLP-1 receptor agonist and a long-acting amylin analogue in a single injection
The new facility is expected to generate 500-600 new jobs in the region
The state-of-the-art facility is expected to be commissioned over the next three years
At one year, the drug met its primary and all key secondary endpoints, delivering significantly better weight maintenance than placebo
Subscribe To Our Newsletter & Stay Updated
